Improvement in the prognosis of ovarian cancer in the era before addition of molecular targeting therapy

Featured Image

Why is it important?

The induction of new chemotherapeutic drugs and the increased variation of second- or third-line chemotherapy affected the improvement in overall survival of patients with advanced epithelial ovarian cancer, even in the era before the addition of molecular targeting therapy.